Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy

BACKGROUND: Tyrosine kinase inhibitors are increasingly used to treat chronic myeloid leukemia (CML), but loss of complete cytogenetic response (CCyR) indicates treatment failure. AIM: To compare the efficacy of Sokal, European Treatment Outcome Study (EUTOS), and Hasford prognostic scores with 3-mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Leiming, Qian, Wei, Yang, Mingzhen, Li, Qingsheng, Liu, Fei, Xie, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573067/
https://www.ncbi.nlm.nih.gov/pubmed/26392775
http://dx.doi.org/10.2147/OTT.S85313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573067/
https://www.ncbi.nlm.nih.gov/pubmed/26392775
http://dx.doi.org/10.2147/OTT.S85313

Ejemplares similares